4.3.6 Emerging therapies

Emerging therapies, based on genetic testing and biomarkers, show promise for treating endometrial cancer. These therapies include:

  • targeted therapies
  • immunotherapies
  • combined therapies (Charo & Plaxe 2019).

The key principle for precision medicine is prompt and clinically oriented communication and coordination with an accredited laboratory and pathologist. Tissue analysis is integral for access to emerging therapies and, as such, tissue specimens should be treated carefully to enable additional histopathological or molecular diagnostic tests in certain scenarios.